These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 27312170)
1. Anti-D treatment for pediatric immune thrombocytopenia: Is the bad reputation justified? Yacobovich J; Abu-Ahmed S; Steinberg-Shemer O; Goldberg T; Cohen M; Tamary H Semin Hematol; 2016 Apr; 53 Suppl 1():S64-6. PubMed ID: 27312170 [TBL] [Abstract][Full Text] [Related]
2. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura. El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649 [TBL] [Abstract][Full Text] [Related]
3. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama. Watts RG Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875 [TBL] [Abstract][Full Text] [Related]
4. Comparison of intravenous immune globulin and high dose anti-D immune globulin as initial therapy for childhood immune thrombocytopenic purpura. Kane I; Ragucci D; Shatat IF; Bussel J; Kalpatthi R Br J Haematol; 2010 Apr; 149(1):79-83. PubMed ID: 20096011 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials. Lioger B; Maillot F; Ternant D; Passot C; Paintaud G; Bejan-Angoulvant T J Pediatr; 2019 Jan; 204():225-233.e8. PubMed ID: 30314658 [TBL] [Abstract][Full Text] [Related]
6. Intravenous immune globulin versus intravenous anti-D immune globulin for the treatment of acute immune thrombocytopenic purpura. Shahgholi E; Vosough P; Sotoudeh K; Arjomandi K; Ansari S; Salehi S; Faranoush M; Ehsani MA Indian J Pediatr; 2008 Dec; 75(12):1231-5. PubMed ID: 19190878 [TBL] [Abstract][Full Text] [Related]
7. Comparison between IV immune globulin (IVIG) and anti-D globulin for treatment of immune thrombocytopenia: a randomized open-label study. Eghbali A; Azadmanesh P; Bagheri B; Taherahmadi H; Sadeghi Sedeh B Fundam Clin Pharmacol; 2016 Aug; 30(4):385-9. PubMed ID: 26991138 [TBL] [Abstract][Full Text] [Related]
8. Anti-D exerts a very early response in childhood acute idiopathic thrombocytopenic purpura. Moser AM; Shalev H; Kapelushnik J Pediatr Hematol Oncol; 2002 Sep; 19(6):407-11. PubMed ID: 12186363 [TBL] [Abstract][Full Text] [Related]
9. Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin. Tarantino MD; Madden RM; Fennewald DL; Patel CC; Bertolone SJ J Pediatr; 1999 Jan; 134(1):21-6. PubMed ID: 9880444 [TBL] [Abstract][Full Text] [Related]
10. Treatment, outcome, and cost of care in children with idiopathic thrombocytopenic purpura. Kumar M; Vik TA; Johnson CS; Southwood ME; Croop JM Am J Hematol; 2005 Mar; 78(3):181-7. PubMed ID: 15726607 [TBL] [Abstract][Full Text] [Related]
11. How we use WinRho in patients with idiopathic thrombocytopenic purpura. Stotler BA; Schwartz J Transfusion; 2015 Nov; 55(11):2547-50. PubMed ID: 26094894 [TBL] [Abstract][Full Text] [Related]
12. A comparison of intravenous immunoglobulin (2 g/kg totally) and single doses of anti-D immunoglobulin at 50 μg/kg, 75 μg/kg in newly diagnosed children with idiopathic thrombocytopenic purpura: Ankara hospital experience. Alioglu B; Ercan S; Tapci AE; Zengin T; Yazarli E; Dallar Y Blood Coagul Fibrinolysis; 2013 Jul; 24(5):505-9. PubMed ID: 23470649 [TBL] [Abstract][Full Text] [Related]
13. Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children. Tarantino MD; Young G; Bertolone SJ; Kalinyak KA; Shafer FE; Kulkarni R; Weber LC; Davis ML; Lynn H; Nugent DJ; J Pediatr; 2006 Apr; 148(4):489-94. PubMed ID: 16647411 [TBL] [Abstract][Full Text] [Related]
14. Anti-D immunoglobulin in the treatment of idiopathic thrombocytopenic purpura. Krishnamurti L; Charan VD; Desai N; Pati H; Choudhry VP Indian J Pediatr; 1994; 61(2):179-82. PubMed ID: 7927616 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the effects of and earliest response rate to anti-D treatment in children with chronic idiopathic thrombocytopenic purpura: a pilot study. Yetgin S; Aytaç S; Olcay L; Tunç B; Ozbek N; Aydinok Y Turk J Pediatr; 2010; 52(2):126-31. PubMed ID: 20560246 [TBL] [Abstract][Full Text] [Related]
16. [Clinical effect of anti-D immunoglobulin in treatment of childhood immune thrombocytopenia: a Meta analysis]. Qin W; Huang SL; Li TT Zhongguo Dang Dai Er Ke Za Zhi; 2017 Oct; 19(10):1070-1076. PubMed ID: 29046203 [TBL] [Abstract][Full Text] [Related]
18. Efficacy, safety, and dose response of intravenous anti-D immune globulin (WinRho SDF) for the treatment of idiopathic thrombocytopenic purpura in children. Freiberg A; Mauger D Semin Hematol; 1998 Jan; 35(1 Suppl 1):23-7. PubMed ID: 9523746 [TBL] [Abstract][Full Text] [Related]
19. First Line Treatments for Newly Diagnosed Primary Immune Thrombocytopenia in Children: A Systematic Review and Network Meta-analysis. Acero-Garcés DO; García-Perdomo HA Curr Pediatr Rev; 2020; 16(1):61-70. PubMed ID: 31656149 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and response to intravenous anti-D immunoglobulin in chronic idiopathic thrombocytopenic purpura. Ramadan KM; El-Agnaf M Clin Lab Haematol; 2005 Aug; 27(4):267-9. PubMed ID: 16048495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]